The global AI-Assisted Drug Discovery Software market size is predicted to grow from US$ 784 million in 2025 to US$ 1411 million in 2032; it is expected to grow at a CAGR of 8.9% from 2026 to 2032.

Global AI-Assisted Drug Discovery Software Market Trends, Growth | CAGR 8.9%

The global AI-Assisted Drug Discovery Software market size is predicted to grow from US$ 784 million in 2025 to US$ 1411 million in 2032; it is expected to grow at a CAGR of 8.9% from 2026 to 2032. AI-AssistedDrug Discovery Software refers to a software system that uses artificial intelligence technology, based on pharmaceutical big data, to quickly analyze drug structure, efficacy, etc. through machine learning, deep learning and other technologies. This type of software is designed to shorten the drug development cycle, save costs, promote new drug discovery and improve the success rate of trials. United States market for AI-Assisted Drug Discovery Software is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. China market for AI-Assisted Drug Discovery Software is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Europe market for AI-Assisted Drug Discovery Software is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Global key AI-Assisted Drug Discovery Software players cover AIDDISON, Atomwise Inc, BenevolentAI, BullFrog AI, Cyclica, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025. LPI (LP Information) newest research report, the AI-Assisted Drug Discovery Software Industry Forecast looks at past sales and reviews total world AI-Assisted Drug Discovery Software sales in 2025, providing a comprehensive analysis by region and market sector of projected AI-Assisted Drug Discovery Software sales for 2026 through 2032. With AI-Assisted Drug Discovery Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-Assisted Drug Discovery Software industry. This Insight Report provides a comprehensive analysis of the global AI-Assisted Drug Discovery Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI-Assisted Drug Discovery Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global AI-Assisted Drug Discovery Software market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-Assisted Drug Discovery Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-Assisted Drug Discovery Software. This report presents a comprehensive overview, market shares, and growth opportunities of AI-Assisted Drug Discovery Software market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; On Premise Software &nbsp;&nbsp;&nbsp; Cloud-Based Software Segmentation by Application: &nbsp;&nbsp;&nbsp; Biopharmaceuticals &nbsp;&nbsp;&nbsp; Pharmaceuticals &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; AIDDISON &nbsp;&nbsp;&nbsp; Atomwise Inc &nbsp;&nbsp;&nbsp; BenevolentAI &nbsp;&nbsp;&nbsp; BullFrog AI &nbsp;&nbsp;&nbsp; Cyclica &nbsp;&nbsp;&nbsp; Exscientia &nbsp;&nbsp;&nbsp; Genesis Therapeutics Inc &nbsp;&nbsp;&nbsp; Insilico Medicine &nbsp;&nbsp;&nbsp; Recursion Pharmaceuticals &nbsp;&nbsp;&nbsp; Verge Genomics

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global AI-Assisted Drug Discovery Software Market Size (2021-2032) &nbsp;2.1.2 AI-Assisted Drug Discovery Software Market Size CAGR by Region (2021 VS 2025 VS 2032) &nbsp;2.1.3 World Current & Future Analysis for AI-Assisted Drug Discovery Software by Country/Region (2021, 2025 & 2032) &nbsp;2.2 AI-Assisted Drug Discovery Software Segment by Type &nbsp;2.2.1 On Premise Software &nbsp;2.2.2 Cloud-Based Software &nbsp;2.2.3 AI-Assisted Drug Discovery Software Market Size by Type &nbsp;2.2.3.1 AI-Assisted Drug Discovery Software Market Size CAGR by Type (2021 VS 2025 VS 2032) &nbsp;2.2.3.2 Global AI-Assisted Drug Discovery Software Market Size Market Share by Type (2021-2026) &nbsp;2.3 AI-Assisted Drug Discovery Software Segment by Application &nbsp;2.3.1 Biopharmaceuticals &nbsp;2.3.2 Pharmaceuticals &nbsp;2.3.3 Others &nbsp;2.3.4 AI-Assisted Drug Discovery Software Market Size by Application &nbsp;2.3.4.1 AI-Assisted Drug Discovery Software Market Size CAGR by Application (2021 VS 2025 VS 2032) &nbsp;2.3.4.2 Global AI-Assisted Drug Discovery Software Market Size Market Share by Application (2021-2026) 3 AI-Assisted Drug Discovery Software Market Size by Player &nbsp;3.1 AI-Assisted Drug Discovery Software Market Size Market Share by Player &nbsp;3.1.1 Global AI-Assisted Drug Discovery Software Revenue by Player (2021-2026) &nbsp;3.1.2 Global AI-Assisted Drug Discovery Software Revenue Market Share by Player (2021-2026) &nbsp;3.2 Global AI-Assisted Drug Discovery Software Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 AI-Assisted Drug Discovery Software by Region &nbsp;4.1 AI-Assisted Drug Discovery Software Market Size by Region (2021-2026) &nbsp;4.2 Global AI-Assisted Drug Discovery Software Annual Revenue by Country/Region (2021-2026) &nbsp;4.3 Americas AI-Assisted Drug Discovery Software Market Size Growth (2021-2026) &nbsp;4.4 APAC AI-Assisted Drug Discovery Software Market Size Growth (2021-2026) &nbsp;4.5 Europe AI-Assisted Drug Discovery Software Market Size Growth (2021-2026) &nbsp;4.6 Middle East & Africa AI-Assisted Drug Discovery Software Market Size Growth (2021-2026) 5 Americas &nbsp;5.1 Americas AI-Assisted Drug Discovery Software Market Size by Country (2021-2026) &nbsp;5.2 Americas AI-Assisted Drug Discovery Software Market Size by Type (2021-2026) &nbsp;5.3 Americas AI-Assisted Drug Discovery Software Market Size by Application (2021-2026) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC AI-Assisted Drug Discovery Software Market Size by Region (2021-2026) &nbsp;6.2 APAC AI-Assisted Drug Discovery Software Market Size by Type (2021-2026) &nbsp;6.3 APAC AI-Assisted Drug Discovery Software Market Size by Application (2021-2026) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe AI-Assisted Drug Discovery Software Market Size by Country (2021-2026) &nbsp;7.2 Europe AI-Assisted Drug Discovery Software Market Size by Type (2021-2026) &nbsp;7.3 Europe AI-Assisted Drug Discovery Software Market Size by Application (2021-2026) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa AI-Assisted Drug Discovery Software by Region (2021-2026) &nbsp;8.2 Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Type (2021-2026) &nbsp;8.3 Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Application (2021-2026) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global AI-Assisted Drug Discovery Software Market Forecast &nbsp;10.1 Global AI-Assisted Drug Discovery Software Forecast by Region (2027-2032) &nbsp;10.1.1 Global AI-Assisted Drug Discovery Software Forecast by Region (2027-2032) &nbsp;10.1.2 Americas AI-Assisted Drug Discovery Software Forecast &nbsp;10.1.3 APAC AI-Assisted Drug Discovery Software Forecast &nbsp;10.1.4 Europe AI-Assisted Drug Discovery Software Forecast &nbsp;10.1.5 Middle East & Africa AI-Assisted Drug Discovery Software Forecast &nbsp;10.2 Americas AI-Assisted Drug Discovery Software Forecast by Country (2027-2032) &nbsp;10.2.1 United States Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.2.2 Canada Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.2.3 Mexico Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.2.4 Brazil Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.3 APAC AI-Assisted Drug Discovery Software Forecast by Region (2027-2032) &nbsp;10.3.1 China AI-Assisted Drug Discovery Software Market Forecast &nbsp;10.3.2 Japan Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.3.3 Korea Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.3.4 Southeast Asia Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.3.5 India Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.3.6 Australia Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.4 Europe AI-Assisted Drug Discovery Software Forecast by Country (2027-2032) &nbsp;10.4.1 Germany Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.4.2 France Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.4.3 UK Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.4.4 Italy Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.4.5 Russia Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.5 Middle East & Africa AI-Assisted Drug Discovery Software Forecast by Region (2027-2032) &nbsp;10.5.1 Egypt Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.5.2 South Africa Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.5.3 Israel Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.5.4 Turkey Market AI-Assisted Drug Discovery Software Forecast &nbsp;10.6 Global AI-Assisted Drug Discovery Software Forecast by Type (2027-2032) &nbsp;10.7 Global AI-Assisted Drug Discovery Software Forecast by Application (2027-2032) &nbsp;10.7.1 GCC Countries Market AI-Assisted Drug Discovery Software Forecast 11 Key Players Analysis &nbsp;11.1 AIDDISON &nbsp;11.1.1 AIDDISON Company Information &nbsp;11.1.2 AIDDISON AI-Assisted Drug Discovery Software Product Offered &nbsp;11.1.3 AIDDISON AI-Assisted Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.1.4 AIDDISON Main Business Overview &nbsp;11.1.5 AIDDISON Latest Developments &nbsp;11.2 Atomwise Inc &nbsp;11.2.1 Atomwise Inc Company Information &nbsp;11.2.2 Atomwise Inc AI-Assisted Drug Discovery Software Product Offered &nbsp;11.2.3 Atomwise Inc AI-Assisted Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.2.4 Atomwise Inc Main Business Overview &nbsp;11.2.5 Atomwise Inc Latest Developments &nbsp;11.3 BenevolentAI &nbsp;11.3.1 BenevolentAI Company Information &nbsp;11.3.2 BenevolentAI AI-Assisted Drug Discovery Software Product Offered &nbsp;11.3.3 BenevolentAI AI-Assisted Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.3.4 BenevolentAI Main Business Overview &nbsp;11.3.5 BenevolentAI Latest Developments &nbsp;11.4 BullFrog AI &nbsp;11.4.1 BullFrog AI Company Information &nbsp;11.4.2 BullFrog AI AI-Assisted Drug Discovery Software Product Offered &nbsp;11.4.3 BullFrog AI AI-Assisted Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.4.4 BullFrog AI Main Business Overview &nbsp;11.4.5 BullFrog AI Latest Developments &nbsp;11.5 Cyclica &nbsp;11.5.1 Cyclica Company Information &nbsp;11.5.2 Cyclica AI-Assisted Drug Discovery Software Product Offered &nbsp;11.5.3 Cyclica AI-Assisted Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.5.4 Cyclica Main Business Overview &nbsp;11.5.5 Cyclica Latest Developments &nbsp;11.6 Exscientia &nbsp;11.6.1 Exscientia Company Information &nbsp;11.6.2 Exscientia AI-Assisted Drug Discovery Software Product Offered &nbsp;11.6.3 Exscientia AI-Assisted Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.6.4 Exscientia Main Business Overview &nbsp;11.6.5 Exscientia Latest Developments &nbsp;11.7 Genesis Therapeutics Inc &nbsp;11.7.1 Genesis Therapeutics Inc Company Information &nbsp;11.7.2 Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Product Offered &nbsp;11.7.3 Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.7.4 Genesis Therapeutics Inc Main Business Overview &nbsp;11.7.5 Genesis Therapeutics Inc Latest Developments &nbsp;11.8 Insilico Medicine &nbsp;11.8.1 Insilico Medicine Company Information &nbsp;11.8.2 Insilico Medicine AI-Assisted Drug Discovery Software Product Offered &nbsp;11.8.3 Insilico Medicine AI-Assisted Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.8.4 Insilico Medicine Main Business Overview &nbsp;11.8.5 Insilico Medicine Latest Developments &nbsp;11.9 Recursion Pharmaceuticals &nbsp;11.9.1 Recursion Pharmaceuticals Company Information &nbsp;11.9.2 Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Product Offered &nbsp;11.9.3 Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.9.4 Recursion Pharmaceuticals Main Business Overview &nbsp;11.9.5 Recursion Pharmaceuticals Latest Developments &nbsp;11.10 Verge Genomics &nbsp;11.10.1 Verge Genomics Company Information &nbsp;11.10.2 Verge Genomics AI-Assisted Drug Discovery Software Product Offered &nbsp;11.10.3 Verge Genomics AI-Assisted Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.10.4 Verge Genomics Main Business Overview &nbsp;11.10.5 Verge Genomics Latest Developments 12 Research Findings and Conclusion

Report	Global AI-Assisted Drug Discovery Software Market Size, Share and Opportunities 2026-2032
Selected License	Multi ID: ILR3911

Buyer Information

Order Summary